Clinical Research Directory
Browse clinical research sites, groups, and studies.
MSOT as Non-invasive Biomarker for Diagnosis and Monitoring of Neuromuscular Diseases
Sponsor: Children's Hospital of Eastern Ontario
Summary
The goal of this study is to learn if Multispectral Optoacoustic Tomographs (MSOT) works to diagnose and follow the course of neuromuscular diseases (NMDs) in children. MSOT scans will be obtained from muscle region to measure hemo/myoglobin, collagen and lipid content/signal and oxygenation in patients with neuromuscular diseases. No additional research activities -other than MSOT - will be done during this study. Existing clinical, laboratory and imaging data from standard-of-care procedures will be correlated with the MSOT data. The expected total duration of the study is approximately 36 months. Repeated measurements will be done to evaluate disease progression and the value of MSOT in NMD.
Official title: Multispectral Optoacoustic Imaging (MSOT) as Non-invasive Biomarker for Diagnosis and Monitoring of Neuromuscular Diseases (MSOT-NMD)
Key Details
Gender
All
Age Range
Any - 18 Years
Study Type
OBSERVATIONAL
Enrollment
240
Start Date
2025-02-07
Completion Date
2028-07
Last Updated
2025-02-12
Healthy Volunteers
No
Conditions
Interventions
Multispectral Optoacoustic Tomography (MSOT)
MSOT scans will be obtained from two muscle region to measure hemo/myoglobin, collagen and lipid content/signal and oxygenation in patient with neuromuscular diseases.
Locations (1)
CHEO
Ottawa, Ontario, Canada